Related Experiment Videos
[Bone marrow scintigraphy using radiocolloids in bone metastases. Sensitivity, specificity, reliability and
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|June 1, 1986
Summary
Bone marrow scintigraphy is not ideal for screening skeletal metastases due to a high false-negative rate, especially in areas with less bone marrow. However, it can detect early marrow lesions and assess extent in advanced cases.
Area of Science:
- Nuclear Medicine
- Oncology
- Radiology
Background:
- Bone marrow scintigraphy is a diagnostic imaging technique.
- Skeletal metastases can be challenging to detect early.
Purpose of the Study:
- To evaluate the sensitivity and specificity of bone marrow scintigraphy for detecting skeletal metastases.
- To determine its suitability as a screening tool for bone marrow involvement.
Main Methods:
- Retrospective analysis of 40 patients with focal skeletal metastases.
- Comparison of bone marrow scintigraphy with radiology and MDP scintigraphy as reference standards.
Main Results:
- Sensitivity varied by skeletal region, with lower sensitivity in areas of minimal bone marrow.
- Overall sensitivity was 0.64, with a 36% false-negative rate for confirmed metastases.
- Marrow scintigraphy occasionally detected lesions before radiographic or bone scintigraphic evidence.
- It effectively demonstrated bone marrow destruction in advanced disease.
Conclusions:
- Bone marrow scintigraphy is not recommended as a primary screening method for skeletal metastases due to its limitations.
- It can provide valuable information in specific scenarios, such as detecting early marrow lesions or assessing extent in advanced disease.
- It may aid in diagnosing conditions with reduced hematopoiesis or diffuse skeletal uptake.